Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Qurient

    Client Virtual Booth

    QURIENT

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Qurient
    korearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    C-dong 801, 242, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13487, Korea
    Telephone
    Telephone
    +82-31-8060-1600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.qurient.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Korea's Qurient inks agreement with TB Alliance for new anti-tuberculosis agent
    Korea's Qurient inks agreement with TB Alliance for new anti-tuberculosis agent

    https://www.biospectrumasia.com/news/26/21886/koreas-qurient-inks-agreement-with-tb-alliance-for-new-anti-tuberculosis-agent.html

    BIOSPECTRUM ASIA
    06 Feb 2023
    Share Share
    Qurient and TB Alliance Announce Exclusive License Agreement for Telacebec
    Qurient and TB Alliance Announce Exclusive License Agreement for Telacebec

    https://www.prnewswire.com/news-releases/qurient-co-ltd-and-tb-alliance-announce-exclusive-license-agreement-for-telacebec-q203-a-new-anti-tuberculosis-agent-301738149.html

    PR NEWSWIRE
    03 Feb 2023
    Share Share
    Qurient Announces Dosing of First Patient in Q702 with KEYTRUDA in Ph1b/2 Study
    Qurient Announces Dosing of First Patient in Q702 with KEYTRUDA in Ph1b/2 Study

    https://www.businesswire.com/news/home/20230202005011/en

    BUSINESSWIRE
    30 Jan 2023
    Share Share
    Qurient Announces Dosing of First Patient in Q901 Phase 1/2 Clinical Study
    Qurient Announces Dosing of First Patient in Q901 Phase 1/2 Clinical Study

    https://www.businesswire.com/news/home/20221123005365/en

    BUSINESSWIRE
    01 Dec 2022
    Share Share
    Qurient Announces Agreement with MSD to Evaluate Q901 With KEYTRUDA
    Qurient Announces Agreement with MSD to Evaluate Q901 With KEYTRUDA

    https://www.bloomberg.com/press-releases/2022-09-14/qurient-announces-collaboration-agreement-with-msd-to-evaluate-selective-cdk7-inhibitor-q901-in-combination-with-keytruda

    BLOOMBERG
    15 Sep 2022
    Share Share
    FDA Clears Qurient's IND Application for Q901 in Cancer Therapy
    FDA Clears Qurient's IND Application for Q901 in Cancer Therapy

    https://www.businesswire.com/news/home/20220208005826/en

    BUSINESSWIRE
    08 Feb 2022
    Share Share
    Qurient Announces U.S. FDA Clearance of IND Application for Q702
    Qurient Announces U.S. FDA Clearance of IND Application for Q702

    https://www.businesswire.com/news/home/20200526005163/en

    BUSINESSWIRE
    26 May 2020
    Share Share
    Qurient Announces U.S. FDA Clearance of IND Application for Q702
    Qurient Announces U.S. FDA Clearance of IND Application for Q702

    https://www.businesswire.com/news/home/20200526005163/en/Qurient-Announces-U.S.-FDA-Clearance-IND-Application

    BUSINESSWIRE
    26 May 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search